A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

March 15, 2024

Study Completion Date

July 31, 2024

Conditions

Healthy Adults

Interventions

DRUG

KP-001

DRUG

Metformin

oral dose of 850 mg Metformin

DRUG

Midazolam

oral dose of 2 mg Midazolam

DRUG

Clarithromycin

oral doses of 1000 mg Clarithromycin

Trial Locations (1)

Parexel Early Phase Clinical Unit - Los Angeles, Glendale